Mindray Medical Buys Rest of Dragonbio Surgical Implant for $73 Million

Mindray Medical, a China medical device maker, will pay $72.6 million to acquire the remaining part of Wuhan Dragonbio Surgical Implant Co. it does not already own. In 2012, Mindray bought a controlling stake in Dragonbio for $35.5 million. Dragonbio, which specializes in trauma, spine, joint implant and fixation orthopedic products, reported revenues of only $7.7 million in 2011. Although Mindray is currently considering a $3.5 billion privatization offer from its management, the company seems to remain interested in M&A. More details.... Stock Symbol: (NYSE: MR) Share this with colleagues: // //